201 related articles for article (PubMed ID: 23983103)
1. CIP2A modulates cell-cycle progression in human cancer cells by regulating the stability and activity of Plk1.
Kim JS; Kim EJ; Oh JS; Park IC; Hwang SG
Cancer Res; 2013 Nov; 73(22):6667-78. PubMed ID: 23983103
[TBL] [Abstract][Full Text] [Related]
2. CIP2A acts as a scaffold for CEP192-mediated microtubule organizing center assembly by recruiting Plk1 and aurora A during meiotic maturation.
Wang H; Choe MH; Lee IW; Namgoong S; Kim JS; Kim NH; Oh JS
Development; 2017 Oct; 144(20):3829-3839. PubMed ID: 28935709
[TBL] [Abstract][Full Text] [Related]
3. Cancerous inhibitor of protein phosphatase 2A (CIP2A) protein is involved in centrosome separation through the regulation of NIMA (never in mitosis gene A)-related kinase 2 (NEK2) protein activity.
Jeong AL; Lee S; Park JS; Han S; Jang CY; Lim JS; Lee MS; Yang Y
J Biol Chem; 2014 Jan; 289(1):28-40. PubMed ID: 24214971
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function.
Golsteyn RM; Mundt KE; Fry AM; Nigg EA
J Cell Biol; 1995 Jun; 129(6):1617-28. PubMed ID: 7790358
[TBL] [Abstract][Full Text] [Related]
5. PCM1 recruits Plk1 to the pericentriolar matrix to promote primary cilia disassembly before mitotic entry.
Wang G; Chen Q; Zhang X; Zhang B; Zhuo X; Liu J; Jiang Q; Zhang C
J Cell Sci; 2013 Mar; 126(Pt 6):1355-65. PubMed ID: 23345402
[TBL] [Abstract][Full Text] [Related]
6. Cancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy target.
Khanna A; Pimanda JE; Westermarck J
Cancer Res; 2013 Nov; 73(22):6548-53. PubMed ID: 24204027
[TBL] [Abstract][Full Text] [Related]
7. P21-activated kinase is required for mitotic progression and regulates Plk1.
Maroto B; Ye MB; von Lohneysen K; Schnelzer A; Knaus UG
Oncogene; 2008 Aug; 27(36):4900-8. PubMed ID: 18427546
[TBL] [Abstract][Full Text] [Related]
8. Polo-like kinase 1-mediated phosphorylation of Forkhead box protein M1b antagonizes its SUMOylation and facilitates its mitotic function.
Zhang J; Yuan C; Wu J; Elsayed Z; Fu Z
J Biol Chem; 2015 Feb; 290(6):3708-19. PubMed ID: 25533473
[TBL] [Abstract][Full Text] [Related]
9. Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications.
Cristóbal I; Rojo F; Madoz-Gúrpide J; García-Foncillas J
Mol Cell Biol; 2016 Jun; 36(12):1734-9. PubMed ID: 27090640
[TBL] [Abstract][Full Text] [Related]
10. The role of CIP2A in cancer: A review and update.
Soofiyani SR; Hejazi MS; Baradaran B
Biomed Pharmacother; 2017 Dec; 96():626-633. PubMed ID: 29035828
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic relevance of the protein phosphatase 2A in cancer.
Cunningham CE; Li S; Vizeacoumar FS; Bhanumathy KK; Lee JS; Parameswaran S; Furber L; Abuhussein O; Paul JM; McDonald M; Templeton SD; Shukla H; El Zawily AM; Boyd F; Alli N; Mousseau DD; Geyer R; Bonham K; Anderson DH; Yan J; Yu-Lee LY; Weaver BA; Uppalapati M; Ruppin E; Sablina A; Freywald A; Vizeacoumar FJ
Oncotarget; 2016 Sep; 7(38):61544-61561. PubMed ID: 27557495
[TBL] [Abstract][Full Text] [Related]
12. APC/C(Cdh1)-dependent degradation of Cdc20 requires a phosphorylation on CRY-box by Polo-like kinase-1 during somatic cell cycle.
Hyun SY; Sarantuya B; Lee HJ; Jang YJ
Biochem Biophys Res Commun; 2013 Jun; 436(1):12-8. PubMed ID: 23643811
[TBL] [Abstract][Full Text] [Related]
13. Normal cells, but not cancer cells, survive severe Plk1 depletion.
Liu X; Lei M; Erikson RL
Mol Cell Biol; 2006 Mar; 26(6):2093-108. PubMed ID: 16507989
[TBL] [Abstract][Full Text] [Related]
14. CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes.
Niemelä M; Kauko O; Sihto H; Mpindi JP; Nicorici D; Pernilä P; Kallioniemi OP; Joensuu H; Hautaniemi S; Westermarck J
Oncogene; 2012 Sep; 31(39):4266-78. PubMed ID: 22249265
[TBL] [Abstract][Full Text] [Related]
15. The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?
de Cárcer G
Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30862113
[TBL] [Abstract][Full Text] [Related]
16. Cip2a promotes cell cycle progression in triple-negative breast cancer cells by regulating the expression and nuclear export of p27Kip1.
Liu H; Qiu H; Song Y; Liu Y; Wang H; Lu M; Deng M; Gu Y; Yin J; Luo K; Zhang Z; Jia X; Zheng G; He Z
Oncogene; 2017 Apr; 36(14):1952-1964. PubMed ID: 27694903
[TBL] [Abstract][Full Text] [Related]
17. Numb regulates stability and localization of the mitotic kinase PLK1 and is required for transit through mitosis.
Schmit TL; Nihal M; Ndiaye M; Setaluri V; Spiegelman VS; Ahmad N
Cancer Res; 2012 Aug; 72(15):3864-72. PubMed ID: 22593191
[TBL] [Abstract][Full Text] [Related]
18. Bimodal Interaction of Mammalian Polo-Like Kinase 1 and a Centrosomal Scaffold, Cep192, in the Regulation of Bipolar Spindle Formation.
Meng L; Park JE; Kim TS; Lee EH; Park SY; Zhou M; Bang JK; Lee KS
Mol Cell Biol; 2015 Aug; 35(15):2626-40. PubMed ID: 26012549
[TBL] [Abstract][Full Text] [Related]
19. Cancerous inhibitor of protein phosphatase 2A promotes premature chromosome segregation and aneuploidy in prostate cancer cells through association with shugoshin.
Pallai R; Bhaskar A; Barnett-Bernodat N; Gallo-Ebert C; Nickels JT; Rice LM
Tumour Biol; 2015 Aug; 36(8):6067-74. PubMed ID: 25736928
[TBL] [Abstract][Full Text] [Related]
20. Polo-like kinase 1 is essential for the first mitotic division in the mouse embryo.
Baran V; Solc P; Kovarikova V; Rehak P; Sutovsky P
Mol Reprod Dev; 2013 Jul; 80(7):522-34. PubMed ID: 23649868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
